PETROS PHARM INC (PTPI) is a publicly traded the market company. As of August 13, 2026, PTPI trades at $0.35 with a market cap of $0 and a P/E ratio of 0.00. PTPI moved -49.11% today. Year to date, PTPI is +0.00%; over the trailing twelve months it is flat. Its 52-week range spans $0.12 to $18.00. Rallies surfaces PTPI's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies tracks politician and congressional stock disclosures for PTPI, including purchases, sales, transaction dates, owners, and reported trade amounts when available.
| Metric | Value |
|---|---|
| Price | $0.35 |
| Market Cap | $0 |
| P/E Ratio | 0.00 |
| EPS | $0.00 |
| Dividend Yield | 0.00% |
| 52-Week High | $18.00 |
| 52-Week Low | $0.12 |
| Volume | 262.72M |
| Avg Volume | 0 |
| Revenue (TTM) | $0 |
| Net Income | $0 |
| Gross Margin | 0.00% |
PTPI analyst coverage data. Average price target: $0.00.